Literature DB >> 8509601

A new kinetic single-stage Limulus amoebocyte lysate method for the detection of endotoxin in water and plasma.

K I Dunér1.   

Abstract

A convenient kinetic chromogenic Limulus amoebocyte lysate (LAL) method, based on components originally intended for a two-stage end-point method, has been developed. The components (LAL and chromogenic substrate) can be pooled and subsequently used in a single-stage kinetic procedure adapted to microplates. With the help of a kinetic software, it is possible to measure over the three log range 0.005-12 EU/ml in one test run--a range considerably wider than the range of the end-point procedure. A good linearity of the log-log standard curve, reflected by coefficients of regression between 0.997 and 1.0, is shown as well as a high-resolution (> 700 s) between the negative control and the lowest standard point. Moreover a good precision (C.V. < 10%) is obtained in both water and plasma, showing the usefulness of the method in different applications. Finally, a strong correlation (r = 0.95-0.99) to other LAL methods is demonstrated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8509601     DOI: 10.1016/0165-022x(93)90043-n

Source DB:  PubMed          Journal:  J Biochem Biophys Methods        ISSN: 0165-022X


  13 in total

1.  Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.

Authors:  V Lorenzo-Zúñiga; C M Rodríguez-Ortigosa; R Bartolí; M-L Martínez-Chantar; L Martínez-Peralta; A Pardo; I Ojanguren; J Quiroga; R Planas; J Prieto
Journal:  Gut       Date:  2006-01-24       Impact factor: 23.059

2.  Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14.

Authors:  F Nicoletti; R Di Marco; P Sacerdote; P Meroni; K Mangano; C Edwards; A Bartorelli; K Bendtzen; A Panerai
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

3.  Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model.

Authors:  M S Palermo; M F Alves Rosa; N Van Rooijen; M A Isturiz
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

4.  Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia.

Authors:  G C Fernandez; M F Lopez; S A Gomez; M V Ramos; L V Bentancor; R J Fernandez-Brando; V I Landoni; G I Dran; R Meiss; M A Isturiz; M S Palermo
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

5.  Endogenous glucocorticoids modulate neutrophil function in a murine model of haemolytic uraemic syndrome.

Authors:  S A Gómez; G C Fernández; G Camerano; G Dran; F A Rosa; P Barrionuevo; M A Isturiz; M S Palermo
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

6.  Impaired neutrophils in children with the typical form of hemolytic uremic syndrome.

Authors:  Gabriela C Fernández; Sonia A Gómez; Carolina J Rubel; Leticia V Bentancor; Paula Barrionuevo; Marta Alduncín; Irene Grimoldi; Ramón Exeni; Martín A Isturiz; Marina S Palermo
Journal:  Pediatr Nephrol       Date:  2005-06-07       Impact factor: 3.714

7.  Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality.

Authors:  M Palermo; F Alves-Rosa; C Rubel; G C Fernández; G Fernández-Alonso; F Alberto; M Rivas; M Isturiz
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

8.  Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome.

Authors:  S A Gómez; G C Fernández; S Vanzulli; G Dran; C Rubel; T Berki; M A Isturiz; M S Palermo
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

Review 9.  Endotoxemia: methods of detection and clinical correlates.

Authors:  J C Hurley
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

10.  Development of an experimental hemolytic uremic syndrome in rats.

Authors:  Elsa Zotta; Nestor Lago; Federico Ochoa; Horacio A Repetto; Cristina Ibarra
Journal:  Pediatr Nephrol       Date:  2008-02-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.